Episodes (Page 31)
✨
Pilot project for collaborative gene therapy reviews.
Owain Millington
Peter Bains
✨
Discussion on sustainability compliance in healthcare.
✨
ILC Therapeutics' hybrid interferon platform.
✨
US leads in obesity drug clinical trials.
✨
Review of 2023 drug launches and M&A outlook for 2024.
Podcast: Current trends in the biotech landscape with Chris Smyth, President, ICON Biotech Solutions
✨
Chris Smyth discusses current trends in the biotech landscape.
✨
Analysis of active deal-making in China's biotech sector in early 2024.
✨
Key US and EU legislation impacting 2023 and 2024.
✨
Robert Chisena discusses AVS's novel pressure wave balloon technology.
Novel Pressure Wave Balloon
✨
Dr. Charles P. Vega discusses Multi-Cancer Early Detection (MCED).
Charles P. Vega
✨
Challenges in rare neurological disease drug development.
Bruce Leuchter
✨
Discussion on clinical trial diversity in the US.
✨
Upcoming clinical catalysts in the biopharma industry.
✨
Review of influential digital health regulations in the US and EU for 2023.
✨
First gene editing FDA approval and US FTC actions.
✨
Growth and impact of FDA's Project Orbis cancer drug program.
✨
Biokin/BMS ADC deal discussed.
✨
AbbVie makes another acquisition.
✨
Impact of EU's CLP revision on fragrance industry materials.
Aurelie Perrichet
✨
Summary of Scrip article on generative AI in pharma.